Quick Answer
Mosaic ImmunoEngineering Inc. reported R&D Expense of $183.9 thousand for fiscal year 2024.
Mosaic ImmunoEngineering Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $183.9K | -57.8% |
| 2023 | $435.4K | -58.5% |
| 2022 | $1.05M | -28.0% |
| 2021 | $1.46M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $16.0K | -59.5% | +0.2% |
| June 30, 2025 | $16.0K | -73.6% | +1.3% |
| March 31, 2025 | $15.8K | -76.5% | -60.1% |
| September 30, 2024 | $39.6K | -53.4% | -34.8% |
| June 30, 2024 | $60.7K | -50.5% | -9.8% |
| March 31, 2024 | $67.3K | -62.2% | -20.7% |
| September 30, 2023 | $84.9K | -59.8% | -30.7% |
| June 30, 2023 | $122.6K | -59.5% | -31.1% |
- Mosaic ImmunoEngineering Inc. showed a decrease of -57.8% in R&D Expense compared to the prior fiscal year.
- Over the 2021–2024 period, Mosaic ImmunoEngineering Inc.’s r&d expense has declined by 87.4% (from $1.46 million to $183.9 thousand).
- The most recent figure is from Mosaic ImmunoEngineering Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: